Utility and feasibility of Phosphodiesterase inhibitors in the treatment COVID-19 patients
IntroductionThe outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and thesubsequent COVID-19 pandemic have indeed presented a global health crisis ofunprecedented magnitude. The rapid spread of the virus, along with the severe health andeconomic impacts it has had on communities around the world, underscores the urgent needfor effective treatments and management of the disease [13-16]. One of the…